Published Guidance, NICE advice and quality standards
Showing 11 to 18 of 18
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Ibrutinib for treating relapsed or refractory mantle cell lymphoma | TA502 | ||
| Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer | TA503 | ||
| Sore throat (acute): antimicrobial prescribing | NG84 | ||
| Lenvatinib with everolimus for previously treated advanced renal cell carcinoma | TA498 | ||
| Glecaprevir–pibrentasvir for treating chronic hepatitis C | TA499 | ||
| Ceritinib for untreated ALK-positive non-small-cell lung cancer | TA500 | ||
| Age-related macular degeneration | NG82 | ||
| Golimumab for treating non-radiographic axial spondyloarthritis | TA497 |